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Upon the publication of the Guidelines for Diagnosis and
Treatment of Anaerobic Infections (2007), as a represen-
tative of Japanese Society of Chemotherapy and Japanese
Association for Anaerobic Infection Research, we would
like to take this opportunity to offer a few comments.
Obligate anaerobes, found in anaerobic environments of
the human mucosa, are more active than facultative
anaerobes and play major roles among the bacteria found
under these circumstances. Both anaerobes and aerobes
found on the mucosa are known to be beneﬁcial for
humans. However, mucosal collapse and other adverse
events can trigger these bacteria to deeply invade tissues,
thereby damaging health. The diseases possibly caused by
anaerobes can be roughly divided into ﬁve categories: (1)
diseases due to tissue invasion by endogenous anaerobes
from the mucosa, (2) diseases due to tissue invasion by
exogenous anaerobes from the environment, (3) diseases
due to toxins produced by anaerobes, (4) diseases due to
disturbance of the normal bacterial ﬂora primarily com-
posed of anaerobes and (5) in-hospital infections due to
anaerobes. We believe that this guideline is extremely
important on an international scale, because it fully
describes diagnosis and treatment of anaerobic infections
as applicable to each medical specialty and disease cate-
gory. Although there may be readers who do not fully agree
with the publication of this guideline, we believe that
guidelines will continue to be developed and improved
over time. We hope that the validity of this guideline will
be veriﬁed by readers and users, with the goal of making it
more complete through the efforts of the many people
involved.
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